Synthesis and Biological Evaluation of Novel N-[3-fluoro-4-(morpholin-4-yl)phenyl]thiazol-2-amine Derivatives as Potent Antibacterial and Anticancer Agents and ADMET

References

• W. O. Foye, T. L. Lemke, and D. A. Williams, Principles of Medicinal Chemistry, 4th ed. (PA: Williams and Wilkins, Media, 2002), 822.
   Google Scholar
• X. Xie, Y. Yan, N. Zhu, and G. Liu, “Benzothiazoles exhibit Broadspectrum Antitumor Activity: their Potency, Structure–Activity and Structure-Metabolism Relationships,” European Journal of Medicinal Chemistry 76 (2014): 67–78. doi:10.1016/j.ejmech.2014.02.007
   PubMed Web of Science ®Google Scholar
• Sima Singh, Daniel Hassan, Hibah M. Aldawsari, Nagashekhara Molugulu, Rahul Shukla, and Prashant Kesharwani, “Immune checkpoint Inhibitors: A Promising Anticancer Therapy,” Drug Discovery Today 25, no. 1 (2020): 223–9. doi:10.1016/j.drudis.2019.11.003
   PubMed Web of Science ®Google Scholar
• Anna Bielenica, Joanna Stefańska, Karolina Stępień, Agnieszka Napiórkowska, Ewa Augustynowicz-Kopeć, Giuseppina Sanna, Silvia Madeddu, Stefano Boi, Gabriele Giliberti, Małgorzata Wrzosek, et al., “Synthesis, Cytotoxicity and Antimicrobial Activity of Thiourea Derivatives Incorporating 3-(Trifluoromethyl)Phenyl Moiety,” European Journal of Medicinal Chemistry 101 (2015): 111–25. doi:10.1016/j.ejmech.2015.06.027
   PubMed Web of Science ®Google Scholar
• B. Parrino, D. Carbone, G. Cirrincione, P. Diana, and S. Cascioferro, “Inhibitors of Antibiotic Resistance Mechanisms: clinical Applications and Future Perspectives,” Future Medicinal Chemistry 12, no. 5 (2020): 357–9. doi:10.4155/fmc-2019-0326
   PubMed Web of Science ®Google Scholar
• M. Kratky, and J. Vinsova, “Salicylanilide N-Monosubstituted Carbamates: synthesis and in Vitro Antimicrobial Activity,” Bioorganic and Medicinal Chemistry. 24, no. 6 (2016): 1322–30. doi:10.1016/j.bmc.2016.02.004
   PubMed Web of Science ®Google Scholar
• A. Turdo, A. Glaviano, G. Pepe, F. Calapà, S. Raimondo, M. E. Fiori, D. Carbone, M. G. Basilicata, V. Di Sarno, C. Ostacolo, et al., “Nobiletin and Xanthohumol Sensitize Colorectal Cancer Stem Cells to Standard Chemotherapy,” Cancers 13, no. 16 (2021): 3927. doi:10.3390/cancers13163927
   PubMed Web of Science ®Google Scholar
• R. Wijnen, C. Pecoraro, D. Carbone, H. Fiuji, A. Avan, G. J. Peters, E. Giovannetti, and P. Diana, “Cyclin Dependent Kinase-1 (CDK-1) Inhibition as a Novel Therapeutic Strategy against Pancreatic Ductal Adenocarcinoma (PDAC),” Cancers 13, no. 17 (2021): 4389. doi:10.3390/cancers13174389
   PubMed Web of Science ®Google Scholar
• Stella Cascioferro, Giovanna Li Petri, Barbara Parrino, Daniela Carbone, Niccola Funel, Cecilia Bergonzini, Giulia Mantini, Henk Dekker, Daan Geerke, Godefridus J. Peters, et al., “Imidazo[2,1-b] [1,3,4]Thiadiazoles with Antiproliferative Activity against Primary and Gemcitabine-Resistant Pancreatic Cancer Cells,” European Journal of Medicinal Chemistry 189 (2020): 112088. doi:10.1016/j.ejmech.2020.112088
   PubMed Web of Science ®Google Scholar
• S. Cascioferro, B. Parrino, G. L. Petri, M. G. Cusimano, D. Schillaci, V. D. Sarno, S. Musella, E. Giovannetti, G. Cirrincione, and P. Diana, “2,6-Disubstituted imidazo[2,1-b][1,3,4]Thiadiazole Derivatives as Potent Staphylococcal Biofilm Inhibitors,” European Journal of Medicinal Chemistry. 157 (2019): 200–10.
   Google Scholar
• M. F. Elsadek, B. M. Ahmed, and M. F. Farahat, “An Overview on Synthetic 2-Aminothiazole-Based Compounds Associated with Four Biological Activities,” Molecules 26 (2021): 1449.
   PubMed Web of Science ®Google Scholar
• D. Juric, F. Janku, J. Rodón, H. A. Burris, I. A. Mayer, M. Schuler, R. Seggewiss-Bernhardt, M. Gil-Martin, M. R. Middleton, J. Baselga, et al., “Alpelisib plus Fulvestrant in PIK3CA-Altered and PIK3CAwild-Type Estrogen Receptor-Positive Advanced Breast Cancer. A Phase 1b Clin Trial,” JAMA Oncology 5, no. 2 (2019): e184475. doi:10.1001/jamaoncol.2018.4475
   PubMed Web of Science ®Google Scholar
• A. Conroy, D. E. Stockett, D. Walker, M. R. Arki, U. Hoch, J. A. Fox, and R. E. Hawtin, “SNS-032 is a Potent and Selective CDK 2, 7 and 9 Inhibitor That Drives Target Modulation in Patient Samples,” Cancer Chemotherapy and Pharmacology 64, no. 4 (2009): 723–32. doi:10.1007/s00280-008-0921-5
   PubMed Web of Science ®Google Scholar
• J. Kim, S. H. Moon, B. T. Kim, C. H. Chae, J. Y. Lee, and S. H. Kim, “A novel Aminothiazole KY-05009 with Potential to Inhibit Traf2- and Nck-Interacting Kinase (TNIK) Attenuates TGF-β1-Mediated Epithelial-to-Mesenchymal Transition in Human Lung Adenocarcinoma A549 Cells,” PLoS ONE 9, no. 10 (2014): e110180. doi:10.1371/journal.pone.0110180
   PubMed Web of Science ®Google Scholar
• A. Jayanthan, Y. Ruan, T. H. Truong, and A. Narendran, “Aurora kinases as Druggable Targets in Pediatric Leukemia: Heterogeneity in Target Modulation Activities and Cytotoxicity by Diverse Novel Therapeutic Agents,” PLoS ONE 9, no. 7 (2014): e102741. doi:10.1371/journal.pone.0102741
   PubMed Web of Science ®Google Scholar
• F. M. Johnson, S. Agrawal, H. Burris, L. Rosen, N. Dhillon, D. Hong, A. Blackwood-Chirchir, F. R. Luo, O. Sy, S. Kaul, et al., “Phase 1 Pharmacokinetic and Drug‐Interaction Study of Dasatinib in Patients with Advanced Solid Tumors,” Cancer 116, no. 6 (2010): 1582–91. doi:10.1002/cncr.24927
   PubMed Web of Science ®Google Scholar
• F. Arshad, M. F. Khan, W. Akhtar, M. M. Alam, L. M. Nainwal, S. K. Kaushik, M. Akhter, S. Parvez, S. M. Hasan, and M. Shaquiquzzaman, “Revealing quinquennial Anticancer Journey of Morpholine: A SAR Based Review,” European Journal of Medicinal Chemistry 167 (2019): 324–56. doi:10.1016/j.ejmech.2019.02.015
   PubMed Web of Science ®Google Scholar
• S. M. R. Hashemian, T. Farhadi, and M. Ganjparvar, “Linezolid: A Review of Its Properties, Function, and Use in Critical Care,” Drug Design, Development and Therapy 12 (2018): 1759–67. doi:10.2147/DDDT.S164515
   PubMed Web of Science ®Google Scholar
• M. R. Petchey, B. Rowlinson, R. C. Lloyd, I. J. S. Fairlamb, and G. Grogan, “Biocatalytic Synthesis of Moclobemide Using the Amide Bond Synthetase McbA Coupled with an ATP Recycling System,” ACS Catalysis 10, no. 8 (2020): 4659–63. doi:10.1021/acscatal.0c00929
   PubMed Web of Science ®Google Scholar
• Danish. Shahzad, Muhammad. Faisal, Ameema. Rauf, and Jian-hua. Huang, “Synthetic Story of a Blockbuster Drug: Reboxetine, a Potent Selective Norepinephrine Reuptake Inhibitor,” Organic Process Research & Development 21, no. 11 (2017): 1705–31. doi:10.1021/acs.oprd.7b00265
   Web of Science ®Google Scholar
• C. V. Junior, A. Danuello, V. D. S. Bolzani, E. J. Barreiro, and C. A. M. Fraga, “Molecular hybridization: A Useful Tool in the Design of New Drug Prototypes,” Current Medicinal Chemistry. 14 (2007): 1829–52.
   PubMed Web of Science ®Google Scholar
• E. Ramya Sucharitha, T. Murali Krishna, R. Manchal, G. Ramesh, and S. Narsimha, “Fused benzo[1,3]Thiazine-1,2,3-Triazole Hybrids: Microwave-Assisted One-Pot Synthesis, in Vitro Antibacterial, Antibiofilm, and in Silico ADME Studies,” Bioorganic & Medicinal Chemistry Letters 47 (2021): 128201. doi:10.1016/j.bmcl.2021.128201
   PubMed Web of Science ®Google Scholar
• S. Narsimha, N. S. Kumar, B. K. Swamy, N. V. Reddy, S. K. A. Hussain, and M. S. Rao, “Indole-2-Carboxylic Acid Derived Mono and Bis 1,4-Disubstituted 1,2,3-Triazoles: Synthesis, Characterization and Evaluation of Anticancer, Antibacterial, and DNA-Cleavage Activities,” Bioorganic & Medicinal Chemistry Letters 26, no. 6 (2016): 1639–44. doi:10.1016/j.bmcl.2016.01.055
   PubMed Web of Science ®Google Scholar
• S. Narsimha, K. N. Sathesh, J. T. Savitha, M. Ravinder, R. M. Srinivasa, and R. N. Vasudeva, “One-Pot Synthesis and Biological Evaluation of Novel 4-[3-Fluoro-4-(Morpholin-4-yl)]Phenyl-1H-1,2,3-Triazole Derivatives as Potent Antibacterial and Anticancer Agents,” Journal of Heterocyclic Chemistry 57, no. 4 (2020): 1655–65. doi:10.1002/jhet.3890
   Web of Science ®Google Scholar
• R. Sreerama, T. N. Swamy, M. Ravinder, N. V. Reddy, and S. Narsimha, “One-Pot Synthesis of Sulfonyl-1H-1,2,3-Triazolylthiomorpholine 1,1-Dioxide Derivatives and Evaluation of Their Biological Activity,” Phosphorus, Sulfur, and Silicon and the Related Elements 196, no. 5 (2021): 455–60. doi:10.1080/10426507.2020.1854257
   Web of Science ®Google Scholar
• N. Manoj Kumar, N. S. Kumar, T. N. Swamy, M. Ravinder, T. M. Krishna, and S. Narsimha, “Benzothiazole-[1,2,3]Triazolo[5,1-a]Isoindoles: Synthesis, Anticancer Activity, Bioavailability and in Silico Studies against Gama-Tubulin Protein,” Journal of Molecular Structure. 1250 (2022): 131722. doi:10.1016/j.molstruc.2021.131722
   Web of Science ®Google Scholar
• K. N. Manoj, N. S. Kumar, T. N. Swamy, S. Rakesh, E. R. Sucharitha, K. Pavan, and S. Narsimha, “Ramachary-Bressy-Wang [3 + 2]Cycloaddition Reaction: Synthesis of Fully Decorated 1,2,3-Triazoles as Potent Anticancer and EGFR Inhibitors,” Journal of Molecular Structure. 1262 (2022): 132975.
   Web of Science ®Google Scholar
• F. Hersi, H. A. Omar, R. A. Al-Qawasmeh, Z. Ahmad, A. M. Jaber, D. M. Zaher, and T. H. Al-Tel, “Design and Synthesis of New Energy Restriction Mimetic Agents: Potent anti-Tumor Activities of Hybrid Motifs of Aminothiazoles and Coumarins,” Scientific Reports 10, no. 1 (2020): 2893. doi:10.1038/s41598-020-59685-x
   PubMed Web of Science ®Google Scholar
• K. S. Battula, S. Narsimha, R. K. Thatipamula, Y. N. Reddy, and V. R. Nagavelli, “Synthesis and Biological Evaluation of (N-(3-Methoxyphenyl)-4-((Aryl-1H-1,2,3-Triazol-4-yl)Methyl) Thiomorpholine-2-Carboxamide 1,1-Dioxide Hybrids as Antiproliferative Agents,” ChemistrySelect 2, no. 29 (2017): 9595–8. doi:10.1002/slct.201701902
   Web of Science ®Google Scholar
• R. Samala, S. K. Nukala, N. S. Thirukovela, V. R. Nagavelli, and S. Narsimha, “Cu(I)-Catalyzed One-Pot Synthesis of [1,2,3]Triazolo[5,1-a]Isoquinolin-6(5H)-One Derivatives as EGFR-Targeting Anticancer Agents,” ChemistrySelect 7, no. 43 (2022): e202203388. doi:10.1002/slct.202203388
   Web of Science ®Google Scholar
• D. E. V. Pires, T. L. Blundell, and D. B. Ascher, “pkCSM: predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures,” Journal of Medicinal Chemistry 58, no. 9 (2015): 4066–72. doi:10.1021/acs.jmedchem.5b00104
   PubMed Web of Science ®Google Scholar
• A. Daina, O. Michielin, and V. Zoete, “SwissADME: A Free Web Tool to Evaluate Pharmacokinetics, Drug-Likeness and Medicinal Chemistry Friendliness of Small Molecules,” Scientific Reports 7 (2017): 42717. doi:10.1038/srep42717
   PubMed Web of Science ®Google Scholar